CENPF and nasopharyngeal carcinoma: CENPF (Centromere Protein F), which displayed distinct expression in samples with viral integration and co‐occurrence of copy number gain, has been identified as a negative prognosis predictor in various cancers, and targeting its farnesylation, in combination with cisplatin, has shown therapeutic promise in nasopharyngeal carcinoma.57, 58